Abstract
Asbestos is a pulmonary carcinogen known to give rise to DNA and chromosomal damage, but the exact carcinogenic mechanisms are still largely unknown. In this study, gene expression arrays were performed on lung tumor samples from 14 heavily asbestos-exposed and 14 non-exposed patients matched for other characteristics. Using a two-step statistical analysis, 47 genes were revealed that could differentiate the tumors of asbestos-exposed from those of non-exposed patients. To identify asbestos-associated regions with DNA copy number and expressional changes, the gene expression data were combined with comparative genomic hybridization microarray data. As a result, a combinatory profile of DNA copy number aberrations and expressional changes significantly associated with asbestos exposure was obtained. Asbestos-related areas were detected in 2p21–p16.3, 3p21.31, 5q35.2–q35.3, 16p13.3, 19p13.3–p13.1 and 22q12.3–q13.1. The most prominent of these, 19p13, was further characterized by microsatellite analysis in 62 patients for the differences in allelic imbalance (AI) between the two groups of lung tumors. 79% of the exposed and 45% of the non-exposed patients (P=0.008) were found to be carriers of AI in their lung tumors. In the exposed group, AI in 19p was prevalent regardless of the histological tumor type. In adenocarcinomas, AI in 19p appeared to occur independently of the asbestos exposure.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Abbreviations
- CGH array:
-
comparative genomic hybridization array
- LOH:
-
loss of heterozygosity
- AI:
-
allelic imbalance
- MSI:
-
microsatellite instability
References
Balsara BR, Testa JR . (2002). Chromosomal imbalances in human lung cancer. Oncogene 21: 6877–6883.
Blyth K, Cameron ER, Neil JC . (2005). The RUNX genes: gain or loss of function in cancer. Nat Rev Cancer 5: 376–387.
Bossolasco M, Lebel M, Lemieux N, Mes-Masson AM . (1999). The human TDE gene homologue: localization to 20q13.1–13.3 and variable expression in human tumor cell lines and tissue. Mol Carcinog 26: 189–200.
Dano L, Guilly MN, Muleris M, Morlier JP, Altmeyer S, Vielh P et al. (2000). CGH analysis of radon-induced rat lung tumors indicates similarities with human lung cancers. Genes Chromosomes Cancer 29: 1–8.
De Rienzo A, Testa JR . (2000). Recent advances in the molecular analysis of human malignant mesothelioma. Clin Ther 151: 433–438.
Fatma N, Jain A, Rahman Q . (1991). Frequency of sister chromatid exchange and chromosomal aberrations in asbestos cement workers. Br J Int Med 48: 103–105.
Gupta N, Miyauchi S, Martindale RG, Herdman AV, Podolsky R, Miyake K et al. (2005). Upregulation of the amino acid transporter ATB0,+ (SLC6A14) in colorectal cancer and metastasis in humans. Biochim Biophys Acta 1741: 215–223.
Hellstrom I, Raycraft J, Hayden-Ledbetter M, Ledbetter JA, Schummer M, McIntosh M et al. (2003). The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma. Cancer Res 63: 3695–3700.
Hoang JM, Cottu PH, Thuille B, Salmon RJ, Thomas G, Hamelin R . (1997). BAT-26, an indicator of the replication error phenotype in colorectal cancers and cell lines. Cancer Res 57: 300–303.
Hyman E, Kauraniemi P, Hautaniemi S, Wolf M, Mousses S, Rozenblum E et al. (2002). Impact of DNA amplification on gene expression patterns in breast cancer. Cancer Res 62: 6240–6245.
Ionov Y, Nowak N, Perucho M, Markowitz S, Cowell JK . (2004). Manipulation of nonsense mediated decay identifies gene mutations in colon cancer cells with microsatellite instability. Oncogene 23: 639–645.
Karjalainen A, Anttila S . (1997). Asbestos exposure and the risk of lung cancer in urban populations. In: Chereminsinoff (ed). Health and Toxicology. Advances in Environmental Control Technology Series: Houston, USA, pp 127–136.
Karjalainen A, Anttila S, Heikkila L, Karhunen P, Vainio H . (1993). Asbestos exposure among Finnish lung cancer patients: occupational history and fiber concentration in lung tissue. Am J Int Med 23: 461–471.
Kettunen E, Anttila S, Seppanen JK, Karjalainen A, Edgren H, Lindstrom I et al. (2004). Differentially expressed genes in nonsmall cell lung cancer: expression profiling of cancer-related genes in squamous cell lung cancer. Cancer Genet Cytogenet 149: 98–106.
Li R, Wang H, Bekele BN, Yin Z, Caraway NP, Katz RL et al. (2006). Identification of putative oncogenes in lung adenocarcinoma by a comprehensive functional genomic approach. Oncogene 25: 2628–2635.
Marczynski B, Czuppon A, Marek W, Reichel G, Baur X . (1994). Increased incidence of DNA double-strand breaks and anti-ds DNA antibodies in blood of workers occupationally exposed to asbestos. Hum Exp Toxicol 13: 3–9.
Marczynski B, Rozynek P, Kraus T, Schlosser S, Raithel HJ, Baur X . (2000). Levels of 8-hydroxy-2′-deoxyguanosine in DNA of white blood cells from workers highly exposed to asbestos in Germany. Mutat Res 468: 195–202.
Marsit CJ, Hasegawa M, Hirao T, Kim D-H, Aldape K, Hinds PW et al. (2004). Loss of heterozygosity of chromosome 3p21 is associated with mutant TP53 and better patient survival in non-small-cell lung cancer. Cancer Res 64: 8702–8707.
Medina PP, Carretero J, Ballestar E, Angulo B, Lopez-Rios F, Esteller M et al. (2005). Transcriptional targets of the chromatin-remodelling factor SMARCA4/BRG1 in lung cancer cells. Hum Mol Genet 14: 973–982.
Michiels S, Koscielny S, Hill C . (2005). Prediction of cancer outcome with microarrays: a multiple random validation strategy. Lancet 365: 488–492.
Nymark P, Wikman H, Ruosaari S, Hollmén J, Vanhala E, Karjalainen A et al. (2006). Identification of specific gene copy number changes in asbestos-related lung cancer. Cancer Res 66: 5737–5743.
Radak Z, Goto S, Nakamoto H, Udud K, Papai Z, Horvath I . (2005). Lung cancer in smoking patients inversely alters the activity of hOGG1 and hNTH1. Cancer Lett 219: 191–195.
Reisman DN, Sciarrotta J, Wang W, Funkhouser WK, Weissman BE . (2003). Loss of BRG1/BRM in human lung cancer cell lines and primary lung cancers: correlation with poor prognosis. Cancer Res 63: 560–566.
Safar AM, Spencer III H, Su X, Coffey M, Cooney CA, Ratnasinghe LD et al. (2005). Methylation profiling of archived non-small cell lung cancers: a promising prognostic system. Clin Cancer Res 11: 4400–4405.
Sakakura C, Hagiwara A, Miyagawa K, Nakashima S, Yoshikawa T, Kin S et al. (2005). Frequent downregulation of the runt domain transcription factors RUNX1, RUNX3 and their cofactor CBFB in gastric cancer. Int J Cancer 113: 221–228.
Sanchez-Cespedes M, Ahrendt SA, Piantadosi S, Rosell R, Monzo M, Wu L et al. (2001). Chromosomal alterations in lung adenocarcinomas from smokers and nonsmokers. Cancer Res 61: 1309–1313.
Sanchez-Cespedes M, Parrella P, Esteller M, Nomoto S, Trink B, Engles JM et al. (2002). Inactivation of LKB1/STK11 is a common event in adenocarcinomas of the lung. Cancer Res 62: 3659–3662.
Selikoff IJ, Hammond EC, Churg J . (1968). Asbestos exposure, smoking, and neoplasia. JAMA 204: 106–112.
Shukla A, Gulumian M, Hei TK, Kamp D, Rahman Q, Mossman B . (2003a). Multiple roles of oxidants in the pathogenesis of asbestos-induced diseases. Free Radic Biol Med 34: 1117–1129.
Shukla A, Ramos-Nino M, Mossman B . (2003b). Cell signaling and transcription factor activation by asbestos in lung injury and disease. Int J Biochem Cell Biol 35: 1198–1209.
Takamochi K, Ogura T, Yokose T, Ochiai A, Nagai K, Nishiwaki Y et al. (2004). Molecular analysis of the TSC1 gene in adenocarcinoma of the lung. Lung Cancer 46: 271–281.
Upadhyay D, Kamp DW . (2003). Asbestos-induced pulmonary toxicity: role of DNA damage and apoptosis. Exp Biol Med 228: 650–659.
Wikman H, Kettunen E, Seppänen JK, Karjalainen A, Hollmen J, Anttila S et al. (2002). Identification of differentially expressed genes in pulmonary adenocarcinoma by using cDNA array. Oncogene 21: 5804–5813.
Acknowledgements
We are grateful to Mrs Päivi Tuominen and Mrs Tuula Stjernvall for excellent technical assistance. We also thank Mrs Helinä Urhonen and Dr Kaisa Salmenkivi for helping with collecting the samples. This work is financially supported by the Academy of Finland Grants 200802 and 207469, Finnish Cancer Foundations, Sigrid Jusélius Foundation, Finnish Work Environment Fund Grant 102125, and Graduate school in Computational Biology, Bioinformatics and Biometry.
Author information
Authors and Affiliations
Corresponding author
Additional information
Supplementary Information accompanies the paper on the Oncogene website (http://www.nature.com/onc).
Supplementary information
Rights and permissions
About this article
Cite this article
Wikman, H., Ruosaari, S., Nymark, P. et al. Gene expression and copy number profiling suggests the importance of allelic imbalance in 19p in asbestos-associated lung cancer. Oncogene 26, 4730–4737 (2007). https://doi.org/10.1038/sj.onc.1210270
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1210270
Keywords
This article is cited by
-
Driver Gene and Novel Mutations in Asbestos-Exposed Lung Adenocarcinoma and Malignant Mesothelioma Detected by Exome Sequencing
Lung (2016)
-
Association of chromosome 19 to lung cancer genotypes and phenotypes
Cancer and Metastasis Reviews (2015)
-
Arsenic, asbestos and radon: emerging players in lung tumorigenesis
Environmental Health (2012)
-
DNA copy number loss and allelic imbalance at 2p16 in lung cancer associated with asbestos exposure
British Journal of Cancer (2009)
-
Pathways affected by asbestos exposure in normal and tumour tissue of lung cancer patients
BMC Medical Genomics (2008)